These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8759906)
1. Age-related changes in factor VII proteolysis in vivo. Ofosu FA; Craven S; Dewar L; Anvari N; Andrew M; Blajchman MA Br J Haematol; 1996 Aug; 94(2):407-12. PubMed ID: 8759906 [TBL] [Abstract][Full Text] [Related]
2. The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery. Ofosu FA; Leclerc J; Delorme F; Craven S; Shafai S; Frewin L; Blajchman MA Br J Haematol; 1992 Oct; 82(2):391-9. PubMed ID: 1329919 [TBL] [Abstract][Full Text] [Related]
3. Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent. Ofosu FA; Levine M; Craven S; Dewar L; Shafai S; Blajchman MA Br J Haematol; 1992 Oct; 82(2):400-5. PubMed ID: 1329920 [TBL] [Abstract][Full Text] [Related]
5. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Silveira A; Karpe F; Johnsson H; Bauer KA; Hamsten A Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1333-9. PubMed ID: 8911271 [TBL] [Abstract][Full Text] [Related]
6. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242 [TBL] [Abstract][Full Text] [Related]
7. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo. Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054 [TBL] [Abstract][Full Text] [Related]
8. Two-chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass : relationship to increased thrombin generation and heparin concentration. Philippou H; Davidson SJ; Mole MT; Pepper JR; Burman JF; Lane DA Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):248-54. PubMed ID: 9974404 [TBL] [Abstract][Full Text] [Related]
9. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. Kazama Y; Hamamoto T; Foster DC; Kisiel W J Biol Chem; 1995 Jan; 270(1):66-72. PubMed ID: 7814421 [TBL] [Abstract][Full Text] [Related]
11. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Bauer KA; Mannucci PM; Gringeri A; Tradati F; Barzegar S; Kass BL; ten Cate H; Kestin AS; Brettler DB; Rosenberg RD Blood; 1992 Apr; 79(8):2039-47. PubMed ID: 1562731 [TBL] [Abstract][Full Text] [Related]
12. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. ten Cate H; Bauer KA; Levi M; Edgington TS; Sublett RD; Barzegar S; Kass BL; Rosenberg RD J Clin Invest; 1993 Sep; 92(3):1207-12. PubMed ID: 8376580 [TBL] [Abstract][Full Text] [Related]
13. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential. Chan AK; Berry LR; Monagle PT; Andrew M Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942 [TBL] [Abstract][Full Text] [Related]
14. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity. Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558 [TBL] [Abstract][Full Text] [Related]
15. Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery. Craven S; Dewar L; Yang X; Ginsberg J; Ofosu F Blood Coagul Fibrinolysis; 2007 Apr; 18(3):219-25. PubMed ID: 17413757 [TBL] [Abstract][Full Text] [Related]
16. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Friederich PW; Levi M; Bauer KA; Vlasuk GP; Rote WE; Breederveld D; Keller T; Spataro M; Barzegar S; Büller HR Circulation; 2001 May; 103(21):2555-9. PubMed ID: 11382723 [TBL] [Abstract][Full Text] [Related]
17. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa. Kondo S; Kisiel W Thromb Res; 1987 Apr; 46(2):325-35. PubMed ID: 3496682 [TBL] [Abstract][Full Text] [Related]
18. [Thrombogenicity of a new prothrombin complex concentrate]. Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940 [TBL] [Abstract][Full Text] [Related]
19. The function of factor XI in tissue factor-initiated thrombin generation. Butenas S; Dee JD; Mann KG J Thromb Haemost; 2003 Oct; 1(10):2103-11. PubMed ID: 14521591 [TBL] [Abstract][Full Text] [Related]
20. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin. Lormeau JC; Herault JP; Herbert JM Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]